Lv1
90 积分 2022-05-26 加入
Targeting CDK2 and other novel cell cycle targets for breast cancer therapy
30天前
已完结
免疫检查点抑制剂在宫颈癌中的应用进展
1个月前
已完结
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
3个月前
已完结
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial
3个月前
已完结
[Chinese expert consensus on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors]
4个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
4个月前
已完结
小分子TKI治疗HER2+乳腺癌脑转移研究进展
4个月前
已完结
安罗替尼在铂耐药卵巢癌中的疗效与安全性观察及预后标志物的探索
5个月前
已完结
抗血管生成药物在铂耐药卵巢癌中的应用进展
5个月前
已完结
抗体偶联药物治疗铂耐药卵巢癌的研究进展
5个月前
已完结
皖公网安备34019202002308
